Novavax Stock Soars 26%. A Vaccine Purchase Settlement Is One Reason Why.

Novavax reaches a settlement related to an advance purchase agreement with Gavi.

Related Keywords

John Jacobs ,Angela Palumbo ,Drug Administration ,Getty Images ,Novavax Chief Executive ,Dow Jones Market ,Wall Street ,Article Normal ,Pharmaceuticals ,Vaccines ,Textiles ,Healthcare Life Sciences ,Clothing Textiles ,Consumer Goods ,Specialized Drugs Medications ,Financial Performance ,Corporate Industrial News ,Political General News ,Respiratory Tract Diseases ,Health ,Immunizations ,Medical Conditions ,Novel Coronaviruses ,Infectious Diseases ,Medical Treatments Procedures ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Biotech And Pharma ,Markets ,North America ,Novavax ,Nvax ,Moderna ,Mrna ,Corporate ,Industrial News ,Political ,General News ,Medical Treatments ,Procedures ,Healthcare ,Life Sciences ,Clothing ,Specialized Drugs ,Medications ,